Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-15

Clinical Trial Update: Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating long-term safety and tolerability of metoprolol versus nebivolol in hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METOPROLOL (METOPROLOL TARTRATE)
  • Nebivolol (Nebivolol)

Snippet

Sponsor: Mylan Bertek Pharmaceuticals | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2022-03-15